A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer
dc.contributor.author | Stegeman, S. | |
dc.contributor.author | Moya, L. | |
dc.contributor.author | Selth, L. | |
dc.contributor.author | Spurdle, A. | |
dc.contributor.author | Clements, J. | |
dc.contributor.author | Batra, J. | |
dc.date.issued | 2015 | |
dc.description | Accepted Preprint first posted online on 10 February 2015 | |
dc.description.abstract | The oncogene MDM4, also known as MDMX or HDMX, contributes to cancer susceptibility and progression through its capacity to negatively regulate a range of genes with tumour suppressive functions. A recent genome wide association study reported that the A-allele of the rs4245739 SNP (A>C), located in the 3'UTR of MDM4, is associated with increased prostate cancer risk. Computational predictions revealed that the rs4245739 SNP is located within a predicted binding site for three microRNAs (miRNA): miR-191-5p, miR-887 and miR-3669. Here, we show using reporter gene assays and endogenous MDM4 expression analyses that miR-191-5p and miR-887 have a specific affinity for the rs4245739 SNP C-allele in prostate cancer. These miRNAs do not affect MDM4 mRNA levels but rather inhibit its translation in C-allele containing PC3 cells but not in LNCaP cells homozygous for the A-allele. By analysing gene expression datasets from patient cohorts, we found that MDM4 is associated with metastasis and prostate cancer progression and that targeting this gene with miR-191-5p or miR-887 decreases PC3 cell viability. This study is the first to demonstrate regulation of the MDM4 rs4245739 SNP C-allele by two miRNAs in prostate cancer, and thereby identifies a mechanism by which the MDM4 rs4245739 SNP A-allele may be associated with increased prostate cancer risk. | |
dc.description.statementofresponsibility | Shane Stegeman, Leire Moya, Luke A. Selth, Amanda B. Spurdle, Judith A. Clements and Jyotsna Batra | |
dc.identifier.citation | Endocrine-Related Cancer, 2015; 22(2):265-276 | |
dc.identifier.doi | 10.1530/ERC-15-0013 | |
dc.identifier.issn | 1351-0088 | |
dc.identifier.issn | 1479-6821 | |
dc.identifier.orcid | Selth, L. [0000-0002-4686-1418] | |
dc.identifier.uri | http://hdl.handle.net/2440/89765 | |
dc.language.iso | en | |
dc.publisher | BioScientifica | |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1050742 | |
dc.rights | © 2015 by the Society for Endocrinology | |
dc.source.uri | https://doi.org/10.1530/erc-15-0013 | |
dc.subject | MDM4 | |
dc.subject | microRNA | |
dc.subject | single nucleotide polymorphism | |
dc.subject | prostate cancer | |
dc.title | A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer | |
dc.type | Journal article | |
pubs.publication-status | Published |